These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Effect of an inosite-nicotinic acid-ester on serum lipid changes in patients with vascular diseases]. Hammerl H, Kränzl C, Pichler, Studlar M. Munch Med Wochenschr; 1969 Sep 19; 111(38):1912-6. PubMed ID: 5394857 [No Abstract] [Full Text] [Related]
13. [Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives]. Orö L. Lakartidningen; 1970 Dec 14; 67():Suppl IV:63+. PubMed ID: 5511953 [No Abstract] [Full Text] [Related]
14. [Serum lipid-lowering drugs following myocardial infarction]. Schettler G. Dtsch Med Wochenschr; 1975 Aug 01; 100(31):1611-2. PubMed ID: 168052 [No Abstract] [Full Text] [Related]
15. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)]. Levy H. Med Klin; 1974 Sep 06; 69(36):1441-7. PubMed ID: 4280008 [No Abstract] [Full Text] [Related]
16. [Treatment with nicotinic acid. II. Clinical experience]. Carlson LA, Orö L. Lakartidningen; 1966 Nov 09; 63(45):4281-7. PubMed ID: 5978872 [No Abstract] [Full Text] [Related]
17. [Therapy of hyperlipemias with lipolytic drugs]. Jover Sanz E, Paradinas Jiménez C, Corporales López L, Martínez Robles JV. Rev Clin Esp; 1974 Jun 15; 133(5):447-50. PubMed ID: 4428087 [No Abstract] [Full Text] [Related]
18. [On the treatment of hyperlipemia with theophylline nicotinate]. Ciammaichella A. Atti Soc Ital Cardiol; 1969 Jan 21; 2():251-60. PubMed ID: 5406537 [No Abstract] [Full Text] [Related]
20. [Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)]. Ferrer García JL. Folia Clin Int (Barc); 1973 Nov 21; 23(11):782-94. PubMed ID: 4773216 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]